Bank of New York Mellon’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-16,912
| Closed | -$5K | – | 4359 |
|
|
2018
Q1 | $5K | Buy |
16,912
+2,503
| +17% | +$740 | ﹤0.01% | 4291 |
|
|
2017
Q4 | $24K | Sell |
14,409
-5,246
| -27% | -$8.74K | ﹤0.01% | 4277 |
|
|
2017
Q3 | $28K | Buy |
19,655
+5,246
| +36% | +$7.47K | ﹤0.01% | 4186 |
|
|
2017
Q2 | $23K | Sell |
14,409
-12,622
| -47% | -$20.1K | ﹤0.01% | 4221 |
|
|
2017
Q1 | $92K | Buy |
27,031
+2,120
| +9% | +$7.22K | ﹤0.01% | 4041 |
|
|
2016
Q4 | $129K | Sell |
24,911
-2,940
| -11% | -$15.2K | ﹤0.01% | 3978 |
|
|
2016
Q3 | $702K | Sell |
27,851
-995
| -3% | -$25.1K | ﹤0.01% | 3367 |
|
|
2016
Q2 | $714K | Buy |
28,846
+81
| +0.3% | +$2.01K | ﹤0.01% | 3356 |
|
|
2016
Q1 | $833K | Buy |
28,765
+4,048
| +16% | +$117K | ﹤0.01% | 3174 |
|
|
2015
Q4 | $918K | Buy |
24,717
+3,141
| +15% | +$117K | ﹤0.01% | 3215 |
|
|
2015
Q3 | $1.05M | Sell |
21,576
-727
| -3% | -$35.4K | ﹤0.01% | 3137 |
|
|
2015
Q2 | $1.54M | Buy |
22,303
+18,360
| +466% | +$1.27M | ﹤0.01% | 3080 |
|
|
2015
Q1 | $141K | Buy |
+3,943
| New | +$141K | ﹤0.01% | 3977 |
|